证券日报网讯12月15日，九洲药业（603456）在互动平台回答投资者提问时表示，公司目前已完成AI 专业团队及服务器的搭建，加快推进AI在药物研发、工艺设计、智能制造以及质量控制等环节的创新 应用。同时，公司也持续开放合作，寻求与外部领先的AI技术平台及科研机构开展协同，共同推进AI 技术在公司全产业链的深度融合与智能化升级。 ...

Group 1 - The core point of the article is that Guotou Zhonglu plans to acquire 100% of the China Electronic Engineering Design Institute, marking its entry into the electronic engineering sector [1][2][3] - The acquisition will be executed through a share issuance to several investors, including Guotou Group and others, and is expected to constitute a major asset restructuring [2][3] - This strategic move aims to transform Guotou Zhonglu's business from concentrated fruit juice production to include industrial consulting, process design, engineering construction, and smart factory solutions [3][4] Group 2 - The transaction is anticipated to enhance Guotou Zhonglu's asset scale, operating income, and net profit attributable to shareholders [4] - In recent years, Guotou Zhonglu has faced significant performance pressure, with a revenue decline of 13.89% in 2023 to 1.487 billion yuan and a net profit drop of 36.79% to 58.22 million yuan [5][6] - However, the company reported a strong recovery in Q1 2025, with a revenue increase of 58.03% to 573 million yuan and a net profit surge of 217.54% to 27.01 million yuan, attributed to higher customer order demand [6]